Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis.
Toshiaki KogameSatoru YonekuraPaola LovatoMasahiro HirataRiko Takimoto-ItoTomoya TakegamiTakayoshi Komatsu-FujiiNaotomo KambeTakashi NomuraMads A RøpkeKenji KabashimaPublished in: The British journal of dermatology (2023)